Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Anxiety: Overview01:18

Anxiety: Overview

527
Anxiety is a common mental disorder featuring excessive worry, fear, and apprehension, significantly affecting daily life. People with anxiety disorders experience persistent and intense anxiety, interrupting their everyday functioning.
Individuals with anxiety often experience a range of physical and emotional symptoms, including sweating, trembling, tachycardia, and disturbances in sleep patterns. These symptoms vary in intensity and frequency but are generally disruptive and distressing.
527
Generalized Anxiety Disorder01:30

Generalized Anxiety Disorder

362
Generalized Anxiety Disorder (GAD) is a chronic condition characterized by excessive and uncontrollable worry that persists for at least six months, significantly interfering with daily functioning. Unlike situational anxiety, which arises in response to specific stressors, GAD often occurs without a clear cause. Individuals may experience disproportionate worry about work, health, or relationships. For instance, a person might continuously fear poor health despite normal medical evaluations or...
362
Panic Disorder01:27

Panic Disorder

327
Panic disorder is an anxiety disorder characterized by recurrent and sudden minutes-long episodes of intense fear, known as panic attacks. These attacks may feel like heart attacks and often happen without warning or a specific cause. They can include symptoms such as rapid heart rate, shortness of breath, chest pain, trembling, sweating, dizziness, and a sense of helplessness. During a panic attack, individuals may feel as though they are experiencing a heart attack or are in a...
327
Anxiolytic Drugs: Overview01:26

Anxiolytic Drugs: Overview

735
Anxiolytic drugs are vital in managing anxiety disorders by effectively alleviating symptoms such as excessive fear, tachycardia, and tremors. There are several classes of anxiolytic medications, each with unique mechanisms of action and potential side effects.
Primary Types of Anxiolytic Drugs
1. Benzodiazepines:
Benzodiazepines bind to the GABA-A receptor in the brain, enhancing GABA's interaction. This action reduces neurotransmission, effectively blocking anxiety-associated limbic...
735
Social Anxiety Disorder01:28

Social Anxiety Disorder

188
Social anxiety disorder, also known as social phobia, is characterized by an intense fear of social situations where one might face humiliation, rejection, embarrassment, or negative evaluation. This disorder leads individuals to avoid activities like casual conversations, public speaking, or seemingly simple tasks such as eating, signing documents, or swimming, in public settings. Its impact extends beyond discomfort, often significantly interfering with daily functioning and quality of life.
188
Anxiolytic Drugs: Benzodiazepines and Buspirone01:29

Anxiolytic Drugs: Benzodiazepines and Buspirone

1.7K
Benzodiazepines are a class of anxiolytic drugs known for their rapid efficacy and high therapeutic-to-lethal dose ratio, but with a potential risk of drug dependence. These drugs are lipophilic, allowing for rapid absorption after oral administration, eventually reaching the central nervous system (CNS). Once in the CNS, benzodiazepines bind to the allosteric site of the GABAA receptor. This binding enhances the inhibitory effects of the neurotransmitter GABA. By doing so, they prevent...
1.7K

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Positive and negative affect influence learning during exposure therapy: Secondary analysis from a randomized controlled trial.

Journal of anxiety disorders·2026
Same author

Expectancy updating predicts anxiety symptom reduction from exposure therapy: Predictive analyses from a randomized clinical trial.

Behaviour research and therapy·2026
Same author

Positive Affect Treatment for Depression, Anxiety, and Low Positive Affect: A Randomized Clinical Trial.

JAMA network open·2026
Same author

Peer Mentor Training and Supervision for a Digital Adolescent Depression Treatment in South Africa and Uganda: Mixed Methods Evaluation.

JMIR mental health·2026
Same author

Testing a hierarchical model of neuroticism and its cognitive facets: Latent structure and prospective prediction of first onsets of anxiety and unipolar mood disorders during 3 years in late adolescence.

Clinical psychological science : a journal of the Association for Psychological Science·2026
Same author

New and emerging treatments for anxiety disorders.

BMJ (Clinical research ed.)·2026

関連する実験動画

Updated: Nov 12, 2025

Social Isolation Model: A Noninvasive Rodent Model of Stress and Anxiety
04:20

Social Isolation Model: A Noninvasive Rodent Model of Stress and Anxiety

Published on: November 11, 2022

4.9K

不安 について

Michelle G Craske1, Murray B Stein2

  • 1Department of Psychology and Department of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles, Los Angeles, CA, USA.

Lancet (London, England)
|June 29, 2016
PubMed
まとめ
この要約は機械生成です。

青春期 に 多い 不安 障害 は 持続 し て 悪化 する 状態 です. 有効な治療には 認知行動療法やSSRIやSNRIのような薬が含まれており 組み合わせたアプローチが有望です

さらに関連する動画

Reducing State Anxiety Using Working Memory Maintenance
08:17

Reducing State Anxiety Using Working Memory Maintenance

Published on: July 19, 2017

7.8K
Using the Threat Probability Task to Assess Anxiety and Fear During Uncertain and Certain Threat
11:18

Using the Threat Probability Task to Assess Anxiety and Fear During Uncertain and Certain Threat

Published on: September 12, 2014

15.4K

関連する実験動画

Last Updated: Nov 12, 2025

Social Isolation Model: A Noninvasive Rodent Model of Stress and Anxiety
04:20

Social Isolation Model: A Noninvasive Rodent Model of Stress and Anxiety

Published on: November 11, 2022

4.9K
Reducing State Anxiety Using Working Memory Maintenance
08:17

Reducing State Anxiety Using Working Memory Maintenance

Published on: July 19, 2017

7.8K
Using the Threat Probability Task to Assess Anxiety and Fear During Uncertain and Certain Threat
11:18

Using the Threat Probability Task to Assess Anxiety and Fear During Uncertain and Certain Threat

Published on: September 12, 2014

15.4K

科学分野:

  • 精神医学と行動科学
  • 臨床心理学

背景:

  • 不安障害は蔓延し 障害を招き 青年期に発症することが多いのです
  • これらの状態は,日常の機能を損なう,持続的な,不均衡な不安によって特徴付けられます.
  • 他の精神疾患と併発することが多いのです

研究 の 目的:

  • 不安障害の概要とその特徴と診断上の考慮事項について説明する.
  • 効果的な心理的および薬学的治療方法を議論する.
  • 治療のアクセシビリティとパーソナライゼーションに関するさらなる研究の必要性を強調する.

主な方法:

  • 文献レビューと不安障害に関する現在の知識の統合.
  • 診断基準と差異診断の検討
  • 既存の治療法と新しい治療法の分析

主要な成果:

  • 不安障害は,その重度と持続性により,一時的なストレス反応とは異なる.
  • 有効な治療には,認知行動療法 (CBT) と薬剤療法 (SSRI,SNRI) が含まれる.
  • 心理学的治療と薬学的治療を組み合わせれば 優れた効果が得られます

結論:

  • 不安障害は 身体的な状態から 慎重に差異診断を 要求します
  • 治療を受けない不安障害は しばしば 慢性的な再発につながります
  • 治療へのアクセスを改善し,パーソナライズされた治療戦略を開発するには,研究を強化することが不可欠です.